brain_esni.jpg
  • 14th ISNI Congress

    14th International Congress of Neuroimmunology
    2nd Global Schools of Neuroimmunology Pre-Course

    August 27-31, 2018 - Brisbane, Australia

    Read more ...  
  • ASNI Charlottesville 2017

    2nd Americas School of Neuroimmunology

    October 3-6, 2017 - Charlottesville (VA), USA

    Read more ...  
  • ISNI SESSION - AAI 2017

    ISNI Session at the Immunology 2017 meeting

    Date: Monday, May 15, 2017
    Time: 10:15 AM - 12:15 PM

     
  • Registration and Abstract Submission

    Registration and Abstract Submission to the XXVI AINI Congress and 16th ESNI Course is open. Check it out here

     
  • Regeneration

    November 16-18, 2017, Milan Italy

    Read more ...  

Woodroofe, Nicola Margot

WoodroofeDate of birth
13 September 1954

Nazionality
British

Phone: 0114 225 3065
fax: 0114 225 3064
mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

EDUCATION AND QUALIFICATIONS

  • 1972 - 1975 Chelsea College, University of London, BSc Biochemistry - First Class Honours
  • 1975 - 1978 Chelsea College, University of London, PhD Biochemistry
  • 1994 - 1995 Sheffield Hallam University Postgraduate Certificate in Further and Higher Education

POSTDOCTORAL EXPERIENCE

  • 1983 - 1990 Research Assistant, Multiple Sclerosis Society Laboratory, Institute of Neurology
  • 1981 - 1983 Research Assistant, Muscular Dystrophy Lab., Institute of Neurology
  • 1980 - 1981 Research Assistant, Biochemistry Dept., Imperial College, London
  • 1978 - 1980 Postdoctoral Fellow of the Muscular Dystrophy Association of America,
    Anatomy Dept., University of Wisconsin, Madison, Wisconsin, USA

EMPLYMENT

  • 2004 - present Head of Biomedical Research Centre
  • 2004 - present Professor in Neuroimmunology, SHU
  • 1998 - 2001 Principal Lecturer in Immunology, SHU
  • 1994 - 1998 Senior Lecturer in Immunology, Sheffield Hallam University (SHU)
  • 1991 -1994 Honorary Lecturer, Institute of Neurology, London

CURRENT GRANTS

  • 2004 - present Head of Biomedical Research Centre
  • 2006 - 2009 Neurology Department, Sheffield Teaching Hospitals Foundation Trust.
    An investigation of the functional role of ADAM17 in human astrocyte and endothelial cells £70,000
  • 2006 - 2009 Joint award from Cardiology Department, Royal Hallamshire Hospital and Sheffield Hallam University.
    Role of fractalkine in atherosclerosis. £70,000.
  • 2007 - 2009 Sheffield Hospitals Charitable Trust. Effect of immunomodulatory treatment on migration
    of peripheral blood mononuclear cells from patients with MS to intact and truncated chemokines.
    (Awarded to Woodroofe and Sharrack) £50,000
  • 2008 - 2010 Multiple Sclerosis Society. An investigation into the functional role of ADAM17
    in MS pathogenesis using viral vector knockdown in vitro and in chronic relapsing
    Experimental autoimmune Encephalomyelitis (CREAE). (£103,000).
  • 2008 - 2011 COLIPA (The European Cosmetic and Toiletry and Perfumary Association). Direct tissue profiling and imaging by Mass Spectrometry as a novel method for the investigation of the inflammatory signals induced.  (€543,666) (Awarded to MR Clench and N Woodroofe)
  • 2008 - 2011 Multiple Sclerosis Society. The role of citrullination of CNS proteins
    in the pathogenesis of multiple sclerosis. (£105K). (Awarded to N Woodroofe and A Cross).

RECENT PUBLICATIONS IN PEER REVIEWED JOURNAL

1. Dhungana S, Sharrack B, Woodroofe N (2009). Idiopathic intracranial hypertension. Acta Neurol Scand, 121, 71-82.

2. Dhungana S, Sharrack B, Woodroofe N (2009). IL-1 beta, TNF and IP-10 in the cerebrospinal fluid and serum are not altered in patients with idiopathic intracranial hypertension compared to controls. Clinical Endocrinology, 71: 896-698.

3. Denney H, Clench MR, Woodroofe MN (2009). Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis. Biochemical and Biophysical Research Communications, 382(2): 341-347.

4. Hurst L.A., Bunning, R. A. D., Couraud, P-O., Romero, I. A., Weksler, B. B., Sharrack, B., Woodroofe, M. N. (2009). Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment. J Neuroimmunol. 120 (1-2): 108-112.

5. Taylor D, Dalton C, Hall A, Woodroofe MN, Gardiner PHE (2009). Recent developments in selenium research. British Journal of Biomedical Science 66(2): 107-116.

6. Dhungana SW, Waters P, Ismail A, Woodroofe N, Vincent Angela, Sharrack B. Absence of aquaporin-4 antibodies in patients with idiopathic intracranial hypertension. Journal of Neurology. 257(7), 1211-1212

7. Hadjivassiliou M, Aeschlimann D, Gruenewald RA, Sanders DS, Sharrack B, Woodroofe N. GAD antibody-associated neurological illness and its relationship to gluten sensitivity. Acta Neurol Scand. Clinical Neurology 123(3), 175-180

8. Waller R, Woodroofe MN, Francese S, Heath PR, Simpson JE (2012). Isolation of enriched glial populations from post-mortem human CNS material by immuno-laser caputre microdissection. Journal of Neuroscience Methods, 208: 108-113

9. Fouillet A, Mawson J, Suliman O, Sharrack B, Romero IA, Woodroofe N (2012) Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breasdt cancer; a randomized controlled trial. Brain Research 1437: 115-126

10. Scott E, Daley AJ, Doll H, Woodroofe N, Coleman RE, Mutrie N, Crank H, Powers HJ, Saxton JM (2013). Effects of an exercise and hypocaloric healthy eating program on biomarkers associated with long-term prognosis after early-stage breasdt cancer: a randomized controlled trial. Cancer Causes & Control, 24: 181-191

Joomla Template by Joomla51.com